HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.

AbstractINTRODUCTION:
Gemcitabine is standard treatment for pancreatic cancer but has limited clinical benefit due to chemoresistance. Nuclear factor-kappaB (NF-κB) can promote chemoresistance and is therefore an attractive therapeutic target. We hypothesize that NF-κB suppression with the novel, orally bioavailable inhibitor dimethylamino parthenolide (DMAPT) will sensitize pancreatic cancer cells to gemcitabine.
METHODS:
BxPC-3, PANC-1, and MIA PaCa-2 human pancreatic cancer cell lines were treated with gemcitabine and/or DMAPT. Effects on the NF-κB pathway were determined by electrophoretic mobility shift assay, ELISA, or Western blot. Proliferation and apoptosis were measured by cell counts and ELISA, respectively. The effect of gemcitabine in vivo was determined using a MIA PaCa-2 heterotopic xenograft model.
RESULTS:
Gemcitabine induced NF-κB activity in BxPC-3, PANC-1, and MIA PaCa-2 cells and decreased the level of the NF-κB inhibitor IκBα in BxPC-3 and PANC-1 cells. DMAPT prevented the gemcitabine-induced activation of NF-κB. The combination of DMAPT/gemcitabine inhibited pancreatic cancer cell growth more than either agent alone. Gemcitabine also induced intratumoral NF-κB activity in vivo.
CONCLUSIONS:
DMAPT enhanced the anti-proliferative effects of gemcitabine in association with NF-κB suppression in pancreatic cancer cells in vitro. Furthermore, gemcitabine induced NF-κB activity in vivo, thus supporting the evaluation of NF-κB-targeted agents to complement gemcitabine-based therapies.
AuthorsBryan K Holcomb, Michele T Yip-Schneider, Joshua A Waters, Joal D Beane, Peter A Crooks, C Max Schmidt
JournalJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (J Gastrointest Surg) Vol. 16 Issue 7 Pg. 1333-40 (Jul 2012) ISSN: 1873-4626 [Electronic] United States
PMID22618517 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antimetabolites, Antineoplastic
  • LC-1 compound
  • NF-kappa B
  • Sesquiterpenes
  • Deoxycytidine
  • Gemcitabine
Topics
  • Animals
  • Antimetabolites, Antineoplastic (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Deoxycytidine (analogs & derivatives, pharmacology, therapeutic use)
  • Drug Resistance, Neoplasm (drug effects, physiology)
  • Electrophoretic Mobility Shift Assay
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Mice
  • Mice, Nude
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Pancreatic Neoplasms (drug therapy, pathology)
  • Sesquiterpenes (pharmacology)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: